Research Overview of Montair Chewable 4mg
Montair Chewable 4mg is a pharmaceutical preparation containing montelukast sodium as the active ingredient, manufactured by Cipla. Montelukast belongs to the class of leukotriene receptor antagonists, specifically targeting the cysteinyl leukotriene type 1 (CysLT1) receptor. This compound is extensively studied in respiratory research for its role in modulating inflammatory pathways associated with bronchoconstriction and allergic responses. The chewable formulation provides researchers with convenient oral administration options for laboratory studies examining dose-response relationships and bioavailability profiles. Montair represents a valuable research tool for investigating leukotriene-mediated inflammatory processes and their therapeutic modulation. Researchers at Stroid UK Shop can access this compound alongside comprehensive documentation for rigorous experimental protocols.
Laboratory Research Applications
In experimental settings, montelukast serves as a selective antagonist for studying cysteinyl leukotriene pathways in inflammatory models. Research applications include investigation of allergic rhinitis mechanisms, exercise-induced bronchoconstriction studies, and aspirin-sensitive respiratory condition models. The compound demonstrates high selectivity for CysLT1 receptors with minimal activity at other leukotriene or prostaglandin receptors, making it valuable for pathway-specific research. Scientists examine its effects on eosinophil recruitment, mast cell degranulation, and cytokine production in controlled laboratory environments. Comparative studies often evaluate montelukast against other anti-inflammatory compounds available through our specialised pharmaceutical research category. The chewable formulation enables precise dosing studies and pharmacokinetic analysis in experimental models requiring oral administration routes.
Compound Specifications
| Active Ingredient | Montelukast Sodium |
|---|---|
| Strength | 4mg per chewable tablet |
| Manufacturer | Cipla Limited |
| CAS Number | Verify with supplier |
| Molecular Formula | Verify with supplier |
| Storage Requirements | Room temperature, dry environment |
| Research Applications | Leukotriene pathway studies, respiratory inflammation |
| Form | Chewable tablets |
Researchers requiring additional research compounds can explore our extensive SARMS collection or peptide research materials for comprehensive experimental protocols.
Research Compliance Information
Montair Chewable 4mg is supplied exclusively for in-vitro laboratory research purposes and is not intended for human consumption or therapeutic use. This product is restricted to qualified research institutions and licensed laboratories conducting approved studies on leukotriene receptor mechanisms and respiratory inflammation pathways. Researchers must ensure appropriate institutional oversight, proper handling protocols, and compliance with relevant laboratory safety guidelines when working with this compound. All experimental work should be conducted within appropriate containment facilities with adequate ventilation and personal protective equipment. This product has not been evaluated for human safety or efficacy and must remain within controlled research environments at all times.
